Strategic Collaboration LatinaBA recently formed a strategic partnership with P95 to accelerate vaccine and infectious disease research in Latin America, presenting a timely entry point for selling collaborative R&D, regulatory, and clinical services in the region.

Infectious Disease Focus The company has active programs across anti-infectives and vaccines including H1N1, RSV, and broad infectious disease indications, indicating opportunity for partnerships in preclinical study support, clinical trial services, and manufacturing scale-up.

Therapeutic Breadth With a diverse portfolio spanning perinatal, orphan diseases, oncology, CNS, dermatology, immunology and more, LatinaBA may need end-to-end CDMO capabilities, regulatory affairs, and quality assurance services to support multi-therapy programs.

Regional Growth Headquartered in Florida with a Latin America focus and a mid-size team, LatinaBA represents a growing regional hub client profile for CRO/CMO outsourcing, regulatory affairs support, and cross-border clinical operations.

Financial Footprint Revenue range of 25 to 50 million USD and a leadership team with regulatory, quality, and clinical operations expertise suggests opportunities for scalable services in contract manufacturing, preclinical to phase II/III support, and strategic financing advisory.